Ian P Keary
3PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Feb 28, 2025
Cost-effectiveness of wastewater and environmental monitoring of respiratory syncytial virus to guide universal infant immunoprophylaxis in Canada.Élisabeth Mercier, John R Fullarton, Bosco A Paes
|Aug 10, 2023
A new cost-utility analysis assessing risk factor-guided prophylaxis with palivizumab for the prevention of severe respiratory syncytial virus infection in Italian infants born at 29-35 weeks' gestational age.Ian P Keary, Roberto Ravasio, John R Fullarton
|Apr 17, 2023
Impact of using the International Risk Scoring Tool on the cost-utility of palivizumab for preventing severe respiratory syncytial virus infection in Canadian moderate-to-late preterm infants.Barry S Rodgers-Gray, John R Fullarton, Xavier Carbonell-Estrany
Pageof 1
